Symposia: Acute Lymphoblastic Leukemias: Therapies Excluding Allogeneic Transplantation
Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Research, Antibody Therapy, Lymphoid Leukemias, ALL, Combination therapy, Fundamental Science, Clinical trials, Adult, Clinical Practice (Health Services and Quality), Bispecific Antibody Therapy, Drug development, Translational Research, Elderly, Drug-drug interactions, Clinical Research, Health outcomes research, Health disparities research, Pediatric, Supportive Care, Diseases, Therapy sequence, Patient-reported outcomes, Treatment Considerations, Biological therapies, Immunology, Immunotherapy, Real-world evidence, Adverse Events, Lymphoid Malignancies, Metabolism, Registries, Young adult , Biological Processes, Study Population, Human, Measurable Residual Disease
Type: Poster
Hematology Disease Topics & Pathways:
Research, Antibody Therapy, Lymphoid Leukemias, ALL, Combination therapy, Fundamental Science, Clinical trials, Adult, Clinical Practice (Health Services and Quality), Bispecific Antibody Therapy, Drug development, Translational Research, Elderly, Drug-drug interactions, Clinical Research, Health outcomes research, Health disparities research, Pediatric, Supportive Care, Diseases, Therapy sequence, Patient-reported outcomes, Treatment Considerations, Biological therapies, Immunology, Immunotherapy, Real-world evidence, Adverse Events, Lymphoid Malignancies, Metabolism, Registries, Young adult , Biological Processes, Study Population, Human, Measurable Residual Disease
Saturday, December 7, 2024: 5:30 PM-7:30 PM
Halls G-H
(San Diego Convention Center)
See more of: Oral and Poster Abstracts
*signifies non-member of ASH